FDA applicant
Biosite Incorporated
FDA records 46 decisions for Biosite Incorporated (San Diego, CA) from 1990 to 2010: 45 510(k) clearances and 1 De Novo grant. Most are in product codes NBC (Test, Natriuretic Peptide) and DKZ (Enzyme Immunoassay, Amphetamine). Its devices cite 42 predicates, 25 of them its own earlier devices. 35 recalls are linked to its devices, 11 Class I.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Biosite Incorporated’s devices, and how often a recall has named them.
FDA decisions per year
2in 2010
2026 so far, outlined.
Recalls per year
1in 2023
Class I Class II/III not classified
Planning a device like Biosite Incorporated’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report